References
- Kuhl JC, DeBoer VK. Genetic diversity of rhubarb cultivars. J Am Soc Hortic Sci 2008;133:587–92
- Lee J-H, Kim JM, Kim CS. Pharmacokinetic analysis of rhein in Rheum undulatum L. J Ethnopharmacol 2003;84:5–9
- Choi SZ, Lee SO, Jang KU, et al. Antidiabetic stilbene and anthraquinone derivatives from Rheum undulatum. Arch Pharm Res 2005;28:1027–30
- Matsuda H, Morikawa T, Toguchida I, et al. Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem 2001;9:41–50
- Sun AN, Li W, Kim JH, et al. Chemical constituents from the root of Polygonum multiflorum and their soluble epoxide hydrolase inhibitory activity. Arch Pharm Res 2014;38:998–1004
- Yang F, Xu Y, Xiong A, et al. Evaluation of the protective effect of Rhei Radix et Rhizoma against α-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acids. J Ethnopharmacol 2012;144:599–604
- Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 2005;289:496–503
- Fleming I. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Trends Pharmacol Sci 2007;28:448–52
- Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 2009;8:794–805
- Node K, Huo Y, Ruan X, et al. Antiinflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999;285:1276–79
- Mullin CA, Hammock BD. Chalcone oxides-potent selective inhibitors of cytosolic epoxide hydrolase. Arch Biochem Biophys 1982;216:423–39
- Imig JD, Zhao X, Capdevila JH, et al. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 2002;39:690–4
- Morisseau C, Hammock BD. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 2005;45:311–33
- Morisseau C, Goodrow MH, Dowdy D, et al. Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci USA 1999;96:8849–54
- Imig JD. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. Cardiovasc Drug Rev 2006;24:169–88
- Kim JH, Tai BH, Yang SY, et al. Soluble epoxide hydrolase inhibitory constituents from Selaginella tamariscina. Bull Korean Chem Soc 2015;36:300–4
- Kim JH, Morgan AMA, Tai BH, et al. Inhibition of soluble epoxide hydrolase activity by compounds isolated from the aerial parts of Glycosmis stenocarpa. J Enzyme Inhib Med Chem 2016;31:640–4
- Lee GY, Kim JH, Choi SK, Kim YH. Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease. Bioorg Med Chem Lett 2015;25:5097–101
- Kim JH, Ryu YB, Lee WS, Kim YH. Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome. Bioorg Med Chem 2014;22:6047–52
- Kim JH, Cho JW, Tai BH, et al. Soluble epoxide hydrolase inhibitory activity of selaginellin derivatives from Selaginella tamariscina. Molecules 2015;20:21405–14
- Lee SW, Hwang BS, Kim MH, et al. Inhibition of LFA-1/ICAM-1-mediated cell adhesion by stilbene derivatives from Rheum undulatum. Arch Pharm Res 2012;35:1763–70
- Ngoc TM, Minh PT, Hung TM, et al. Lipoxygenase inhibitory constituents from rhubarb. Arch Pharm Res 2008;31:598–605
- Waffo TP, Fauconneau B, Deffieux G, et al. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from vitis vinifera cell cultures. J Nat Prod 1998;61:655–7
- Kang SC, Lee CM, Choung ES, et al. Antiproliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum. Arch Pharm Res 2008;31:722–6